LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 126 participants.

Also called NCT07705594

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 126 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07705594
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07705594. Randomized; no masking; primary purpose treatment. Start 2024-10-09 (actual); primary completion 2026-03-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation
Condition
Tricuspid Regurgitation (TR)
Intervention (Device)
Transvenous Tricuspid Valve System implantation + OMT
Intervention (Drug)
OMT
Lead sponsor
Jenscare Scientific (class: industry)

Record details

Record id
cardio:ct-nct07705594
Content hash
915fb7f83e12967e1804512f57e54c52ac8954a9f0e40d4286f70c26be87584a